Article

Anlotinib inhibits the development of esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway

2023-02-24

Abstract excerpt

<h4>Background: </h4> Anlotinib, a small molecule multi-targeted tyrosine kinase inhibitor, is widely used in the treatment of various diseases. This study aimed to investigate the potential therapeutic effects and possible molecular mechanisms of anlotinib on esophageal squamous cell carcinoma (ESCC) . <h4>Methods: </h4>: Cell viability was detected by CCK-8 assay. Wound-healing and transwell assay were used to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a7ba9f4c-34dc-5b20-900e-0edbc5e48f49
DOI: 10.21203/rs.3.rs-2600904/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Anlotinib inhibits the development of esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathwayDOI 10.21203/rs.3.rs-2600904/v1Read

Identification and validation of an anoikis-related gene signature based on machine learning algorithms in esophageal squamous cell carcinomaSemantic proximity Read

Anlotininb as a Promising Inhibitor on Tumor Growth of Oral Squamous Cell Carcinoma Through Cell Apoptosis and Mitotic CatastropheSemantic proximity Read

NEK2 Promotes the Migration, Invasion, Proliferation and Drug Resistance of ESCC Through the E2F1-IGF2 PathwaySemantic proximity Read

CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinomaSemantic proximity Read

Identification of the antitumor effects of Apigenin against tongue squamous cell carcinoma on the basis of experimental validation and bioinformatics analysisSemantic proximity Read

Identification and functional significance of MicroRNAs in esophageal squamous cell carcinomaSemantic proximity Read

Inhibition of Esophageal Squamous Cell Carcinoma Progression by MIR210HG and Activation of the P53 Signaling Pathway to Promote Apoptosis and AutophagySemantic proximity Read

NEK2 could act as a circadian time-dependent tumor suppressor gene and biomarker in esophageal squamous cell carcinomaSemantic proximity Read

Construction of a survival model for Esophageal Squamous Carcinoma and prediction of potential treatment with herbal medicineSemantic proximity Read

Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinomaSemantic proximity Read

Antitumor activity of Gilteritinib, an inhibitor of AXL, in human solid tumorSemantic proximity Read

TRAIL Promotes Epithelial-to-mesenchymal Transition by Inducing PD-L1 Expression in Esophageal Squamous Cell CarcinomasSemantic proximity Read